251 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A354200

NGeneBio
₩3,180.00-5.4%-54.0%₩41.0bn/aPS10.6xn/an/a

A080720

Union Korea Pharm
₩5,640.001.8%-0.5%₩40.8bn/aPB1.5xn/an/a

A036480

Daesung Microbiological Labs
₩10,610.00-1.9%-10.1%₩40.3bn/aPS1.6xn/a0%

A114450

Green Lifescience
₩2,010.00-0.5%-30.6%₩40.2bn/aPS1.6xn/an/a

A053950

Kyung Nam PharmLtd
₩1,085.00-3.0%-35.0%₩38.6bn/aPB0.5xn/an/a

A018680

Seoul Pharma
₩3,290.00-0.9%-24.0%₩38.4bn/an/an/an/a

A456190

Curachem
₩21,000.00n/a10.5%₩36.8bn/an/an/an/a

A299660

Cellid
₩2,655.00-6.7%-67.1%₩36.1bn/aPB0.9xn/an/a

A043090

TechnologyLtd
₩498.003.3%-65.7%₩35.3bn/aPS2xn/an/a

A086060

GeneBioTech Ltd
₩3,970.000.5%-8.9%₩34.2bn/aPE13.1xn/a0%

A343090

HLB SCIENCE
₩2,055.001.0%-14.4%₩33.7bn/an/an/an/a

A018620

WooGene B&G
₩1,144.00-2.8%-26.5%₩33.0bn/aPB1xn/an/a

A246250

SLS BIO
₩4,685.000.4%-31.7%₩32.0bn/an/an/an/a

A950220

NeoImmuneTech
₩1,584.00-7.6%-33.2%₩31.3bn/aPB0.5xn/an/a

A311960

AItheNutrigene
₩10,000.003.7%-39.6%₩30.6bn/an/an/an/a

A331920

Celemics
₩3,540.00-6.8%-22.6%₩28.9bn/aPS4.4xn/an/a

A179530

ADBiotech
₩3,145.008.8%-24.5%₩28.7bn/aPS2.8xn/an/a

A446440

Epibiotech
₩10,970.006.9%n/a₩25.2bn/an/an/an/a

A341170

Future Medicine
₩2,270.00-21.3%-66.7%₩21.1bn/an/an/an/a

A322970

Moogene Medi
₩2,090.00-4.6%-31.6%₩20.9bn/an/an/an/a

A233250

Median Diagnostics
₩11,400.0014.0%-38.3%₩19.9bn/an/an/an/a

A244460

OLIPASS
₩500.004.0%-73.7%₩17.4bn/aPS3.3xn/an/a

A215380

WOOJUNG BIO
₩1,209.00-6.8%-59.7%₩17.0bn/aPB0.8xn/an/a

A251280

Angiolab
₩5,610.00-6.5%-16.8%₩16.8bn/an/an/an/a
Page 10 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.